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Introduction
Cardiovascular disease (CVD) is the leading cause for 
morbidity and mortality in patients with type 2 diabetes 
(T2DM). Subclinical left ventricular diastolic dysfunction 
(LVDD) is an early indicator of abnormal myocardial func-
tion in this population.1 In fact, the prevalence of LVDD in 
those with T2DM is between 65% and 75% in women and 
35% and 45% in men.2 Furthermore, up to 75% of those with 
LVDD have preserved left ventricular (LV) systolic function 
as measured by LV ejection fraction (LVEF).3,4
Although early screening for LVDD is considered 
important in T2DM management, it can be expensive, 
requires advanced technology, needs staff expertise, and 
is time consuming. Thus, predictors that are practical and 
simple to measure need to be identified. Currently, there are 
several conditions that may predict LVDD, including chronic 
obstructive pulmonary disease (COPD), hypertension, isch-
emic heart disease, diabetes, obesity, and systolic dysfunc-
tion, independent of age and sex.5–8 However, to date, little is 
known about their relationship to the severity of the LVDD in 
patients with T2DM who were already experiencing reduced 
diastolic function.
Obesity, reduced physical activity, and reduced exer-
cise capacity are risk factors for both T2DM and CVD.9,10 
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AbstrAct: Left ventricular diastolic dysfunction (LVDD) is one of the earliest signs for abnormal cardiac function in patients with type 2 diabetes 
(T2DM). It is important to explore the risk factors that will assist in identifying the severity of the LVDD in this population. We examined the influ-
ences of fitness and fatness on the level of left ventricular (LV) impairment in patients with T2DM. Twenty-five patients (age: 64.0 ± 2.5 years, body 
mass index [BMI] = 36.0 ± 1.5 kg/m2, mean ± standard error of measurement) with T2DM and preserved systolic function, but impaired diastolic 
function, mitral valve (MV) E/e′, participated in the study. LV function was assessed using a stress echocardiograph, aerobic power was assessed with 
a sign- and symptom-limited graded exercise test, and the fatness level was assessed using Dual-energy X-ray absorptiometry and BMI. Patients in the 
higher 50% of BMI had higher lateral and septal MV E/e′ (∼34% and ∼25%, respectively, both P , 0.001), compared to those in the lower 50% of BMI, 
with no difference in LV ejection fraction (LVEF) (P . 0.05). In addition, a higher BMI correlated with a higher lateral (r = 0.62, P , 0.001) and septal 
(r = 0.56, P , 0.01) E/e′. There was no such relationship for VO2peak. BMI and VO2peak were not correlated with LV systolic function (ejection fraction). 
In individuals with T2DM and diastolic dysfunction, a higher BMI was associated with worsening diastolic function independent of their aerobic capac-
ity. The data provide a simple and practical approach for clinicians to assist in the early identification and diagnostics of functional changes in the heart 
diastolic function in this population.
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Additionally, patients with T2DM are characterized by a 
reduced aerobic capacity (VO2peak) compared to nondiabet-
ics,1,11 which is correlated with a higher risk of cardiovascular 
and all-cause mortality observed in this group.1 In contrast, 
increased physical activity in patients with T2DM and CVD 
may improve myocardial function, glycemic control, and 
cardiorespiratory fitness and perhaps ultimately contribute 
to reduce the risk of morbidity and premature mortality.9,12 
Interestingly, the associations between fitness and fatness 
with LVDD severity in patients with T2DM who have estab-
lished LVDD, but preserved systolic function, are not clear 
but may be clinically significant as it may not be practically 
possible to screen all patients for LVDD. In addition, it may 
be used as a simple and low-cost tool to predict the sever-
ity of LVDD in this population. As such, the main purpose 
of this study was to examine whether fitness and fatness are 
related to the severity of LVDD in patients with T2DM hav-
ing established isolated diastolic dysfunction (ie, preserved 
systolic function). We hypothesized that patients with higher 
body mass index (BMI) and lower fitness levels would have 
poorer LV diastolic function.
Methods
Twenty-five (male/female [M/F] = 12/13) patients (age: 
64.0 ± 2.5 years, BMI = 36.0 ± 1.5 kg/m2, mean ± standard 
error of measurement [SEM]) with T2DM (fasting glu-
cose = 9.4 ± 0.7 mmol/L) participated in this study (Table 1). 
Patients were recruited from Austin Health (Hospital), 
Melbourne, Australia, over a period of two years. Patients with 
established diagnosis of T2DM requiring pharmacological 
therapy were included if their medications were not modified 
in the past three months (ie, clinically stable state) and had 
impaired diastolic function at peak exercise as assessed on stress 
echocardiography. Impaired diastolic dysfunction was defined 
as an early velocity of MV septal annulus (e′) ,8 cm/seconds 
and either a deceleration time (DT) .220 ms or E/e′ .10.13–15 
Exclusion criteria included history of lung disease requiring 
regular inhaler use, LVEF ,45%, uncontrolled diabetes (hemo-
globin A1c [HbA1c] .9.0%), occult coronary artery disease, or 
evidence of myocardial ischemia on stress echocardiography.
Each participant received written and verbal explanations 
about the nature of the study before signing an informed con-
sent. The study protocol was approved (H2010-03936) by the 
Human Research Ethics Committees of both Austin Health 
and Victoria University, Melbourne.
The study protocol has been previously described in 
detail.15 Participants underwent a signs- and symptoms-limited 
graded exercise stress test for cardiac and aerobic power assess-
ments, dual-energy X-ray absorptiometry (DXA) scanning 
for the assessment of body composition, and a fasting blood 
test for the assessment glucose and lipid concentrations. Our 
study was approved by Austin Health, Human Research Ethics 
Committee, approval number H2010/03936 which complied 
with the Declaration of Helsinki.
stress echocardiography. All eligible participants had 
an evaluation of diastolic function with echocardiography 
imaging while in stable state. Exercise stress echocardiography 
was performed using a symptom-limited graded exercise on a 
Cybex MET 100 cycle (Cybex Metabolic Systems). Images of 
the left ventricle in motion and hemodynamic measures were 
recorded immediately after exercise. The following measures 
were assessed: MV DT (m/second), MV early wave for mitral 
inflow (MV E, m/second), MV ratio of E and A waves of mitral 
inflow (MV E/A), MV early diastolic annular velocity (e′) lat-
eral (m/second), MV e′ septal (m/second), MV E/e′ (lateral), 
and MV E/e′ (septal), where E/e′ = ratio of E and e′, which is 
a noninvasive estimate of LV filling pressure.16,17 Septal refers 
to measurements at the septal MV annulus; lateral refers to 
Table 1. group characteristics.
MEAn ± SEM
sex (M/F) 12/13
age (yrs) 64.0 ± 2.5
Weight (kgs) 96.0 ± 4.9
height (cm) 163.4 ± 2.4
BMi (kg⋅m−2) 36.0 ± 1.5
sBP (mmhg) 135.5 ± 4.0
dBP (mmhg) 81.0 ± 2.5
Vo2peak (ml⋅kg−1⋅min−1) 18.0 ± 0.7
hba1c (%) 7.9 ± 0.2
Fasting glu (mmol⋅l−1) 9.4 ± 0.7
total Chol (mmol⋅l−1) 4.0 ± 0.2
hdl (mmol⋅l−1) 1.2 ± 0.1
ldl (mmol⋅l−1) 2.0 ± 0.1
triglycerides (mmol⋅l−1) 1.6 ± 0.2
Fat (%) 39.0 ± 1.6
Medications (n)
Metformin 19
sulphonylureas/glucazide 14
insulin 12
other anti-diabetic 9
lipid lowering 22
aspirin/Warfarin 7
aCe inhibitors/arBs 17
β-blockers 5
Calcium Channel Blockers 7
other anti-hypertensive 2
diuretics 9
other 22
ex-smoker 9
Abbreviations: BMi, body mass index; sBP, systolic blood pressure; dBP, 
diastolic blood pressure; fasting glu, fasting blood glucose; total chol, total 
cholesterol; hdl, high-density lipoprotein; ldl, low-density lipoprotein; 
arBs, angiotensin ii receptor blockers. other (antidepressants, ostelin, pain 
reliefs, alendronate, glucosamine, colofac, ventolin, and nexium).
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measurements at the lateral annulus. LVEF is expressed as 
percentage and was assessed before exercise.
Aerobic power. Aerobic power (VO2peak) was assessed 
during the same sign- and symptom-limited graded exercise 
test performed for stress echocardiography, which was started 
after a five-minute period of rest. The protocol included an ini-
tial intensity of 25 W and increased to 40 W after 1 minute, 
followed by increments of 20 W/minute for males and 
10 W/minute for females. The test was terminated when a par-
ticipant’s rating of perceived exertion reached very hard (Borg 
scale = 17). Expired respiratory gases were collected through a 
breath-by-breath (B×B) pneumotach system connected to gas 
analyzers. The B×B data were integrated for each 15 seconds 
interval. The gas analyzer was calibrated immediately before 
each test using gases that had been calibrated at alpha stan-
dard. Heart rate was measured at rest and during the incremen-
tal test by 12-lead electrocardiography (Mortara, X-Scribe II). 
Participants had been asked not to consume caffeine or alcohol 
for a minimum of 2 hours prior to exercise test.
body composition. DXA (GE Lunar Pxodigy, Software 
version 9.1) was used to assess total body fat percentages as 
described previously.18,19 All DXA measurements were per-
formed at the Bone Density Unit, Austin Health. BMI was 
measured by mass (kg) divided by height squared.
A fasting blood sample. A blood sample was collected 
following overnight fast. Blood was analyzed for HbA1c (%), 
fasting blood glucose (mmol/L), high-density lipoprotein 
(HDL, mmol/L), total cholesterol (mmol/L), low-density 
lipoprotein (mmol/L), and triglycerides (mmol/L) at Austin 
Health as described previously.18,19
statistical analysis. Due to the cross-sectional nature of 
the study, patients’ characteristics were stratified as being in 
the higher or lower 50% of BMI, VO2peak, and LVDD (E/e′), 
and an unpaired t-test was used to compare between groups 
(ie, high vs low for each respective comparison). A Spearman’s 
rho correlation was used to assess the correlation between 
BMI and VO2peak with LV parameters. Data are reported as 
mean ± SEM, and all statistical analyses were conducted at the 
95% level of significance.
results
Stratified patients’ characteristics are summarized in Table 2. 
There were no significant differences in age, HbA1c, and lipid 
profiles between groups (all P . 0.05) with the exception of 
HDL that was lower in patients with higher BMI. BMI was 
correlated with total body fat (kg; r = 0.94, P , 0.001) and 
total fat percentage (%; r = 0.69, P = 0.01).
Patients with higher BMI had higher degree of diastolic 
dysfunction. Lateral and septal E/e′ were higher in the higher 
50% of BMI (by ∼34% and ∼25%, respectively, both P , 0.001), 
compared to those in the lower 50% of BMI (Table 3). BMI 
significantly correlated with lateral (r = 0.62, P , 0.001) and 
septal (r = 0.56, P , 0.01) E/e′.
No significant difference in measures of systolic function, 
LVEF, was observed between those in higher and lower 50% 
of BMI (Table 3).
Diastolic dysfunction was not different between those 
in the higher 50% of aerobic power compared to those in 
the lower 50% (Table 3), despite a significant difference 
in VO2peak between the groups (20.6 ± 0.6 vs 15.6 ± 0.7, 
P , 0.001; Table 2). LVEF tended to be higher (∼5%, 
P = 0.07) in those with higher aerobic power (Table 3). 
Aerobic power was not correlated with both diastolic and 
systolic measures.
Table 2. Characteristics of patients stratified as higher 50% or lower 50% of the cohort.
BMI (kg⋅M−2) VO2PEAk (ML⋅kg−1⋅MIn−1) LV DIASTOLIC funCTIOn (E/e')
,50% .50% ,50% .50% ,50% .50%
age (yrs) 64.8 ± 3.2 61.0 ± 3.5 63.6 ± 3.7 60.9 ± 3.9 62.1 ± 3.5 65.7 ± 3.5
BMi (kg⋅m−2) 30.1 ± 1.1 41.9 ± 1.5*** 35.4 ± 1.8 34.4 ± 2.4 32.7 ± 1.4 39.3 ± 2.4*
sBP (mmhg) 134.4 ± 6.7 134.6 ± 4.7 127.3 ± 4.7 139.0 ± 7.5 136.9 ± 5.7 134.2 ± 5.7
dBP (mmhg) 82.2 ± 2.9 79.2 ± 4.5 74.6 ± 4.1 84.0 ± 3.4 83.0 ± 2.3 79.2 ± 4.5
Fat (%) 35.0 ± 1.5 43.0 ± 2.0** 37.8 ± 1.8 39.6 ± 2.4 39.0 ± 2.0 39.06 ± 2.4
Vo2peak (ml⋅kg−1⋅min−1) 18.3 ± 0.6 17.6 ± 1.4 15.6 ± 0.7 20.6 ± 0.6*** 19.5 ± 0.8 16.3 ± 1.1*
hba1c (%) 8.2 ± 0.2 7.4 ± 0.3^ 7.9 ± 0.2 7.6 ± 0.4 7.9 ± 0.3 7.9 ± 0.3
Fasting glu (mmol⋅l−1) 9.6 ± 0.9 8.3 ± 0.7 8.5 ± 0.7 8.6 ± 0.7 9.1 ± 0.9 9.9 ± 1.1
tot Chol (mmol⋅l−1) 4.1 ± 0.4 3.8 ± 0.3 3.8 ± 0.3 3.7 ± 0.3 4.2 ± 0.3 3.7 ± 0.3
hdl (mmol⋅l−1) 1.3 ± 0.1 1.1 ± 0.1* 1.2 ± 0.1 1.1 ± 0.1 1.3 ± 0.1 1.2 ± 0.1
ldl (mmol⋅l−1) 2.1 ± 0.2 2.0 ± 0.2 1.9 ± 0.2 1.8 ± 0.2 2.2 ± 0.2 1.8 ± 0.2
triglycerides (mmol⋅l−1) 1.6 ± 0.2 1.7 ± 0.3 1.4 ± 0.1 1.7 ± 0.3 1.7 ± 0.2 1.6 ± 0.3
notes: *P # 0.05, **P # 0.01, ***P # 0.001, and ^P = 0.07 between groups. a higher E/e′ indicates lower left ventricular diastolic function. 
Abbreviations: BMi, body mass index; sBP, systolic blood pressure; dBP, diastolic blood pressure; fasting glu, fasting blood glucose; total chol, total cholesterol; 
hdl, high-density lipoprotein; ldl, low-density lipoprotein.
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discussion
Patients with T2DM and echocardiographic evidence of 
LVDD exhibited higher LV filling pressure as estimated by 
E/e′ (both lateral and septal) if they were in the higher 50% for 
BMI. Similar relationships were not evident for those in the 
lower 50% of VO2peak.
It is previously reported that there is a link between meta-
bolic control of blood glucose (normal blood glucose, impaired 
fasting glucose, and T2DM) and LV structure and func-
tion.4,20–24 In fact, the degree of LVDD appears to increase with 
the duration of T2DM (.4 years post-diagnosis) and more 
severe impaired glucose metabolism.20,25 In addition, LVDD is 
often present in those with impaired glucose tolerance, despite 
a lack of outward symptoms.4 Given that it is not always fea-
sible to screen all patients for LVDD, it is important to iden-
tify related, low cost, and easy to measure predictors that may 
assist in the early identification of patients at a higher risk for 
LVDD. In this study, we have examined two potential low-cost 
factors: BMI, as a measure of fatness, and VO2peak, as a measure 
of aerobic capacity as potential predictors for LVDD.
We reported that BMI strongly correlated with whole 
body fatness (measured by DXA) in this population and as 
such it can be used as a low-cost and easy to measure option 
to quantify obesity levels. In the current study, BMI was cor-
related with LVDD in patients with T2DM. It has been previ-
ously reported that BMI is an independent predictor of LVDD; 
and furthermore, overweight and obesity have a negative 
impact on diastolic function.26,27 The prevalence of LVDD in 
patients with T2DM was reported to be related to the fatness 
level and increases from 25% in those with normal weight to 
30%–50% in overweight/obesity individuals and up to 57% in 
patients who are morbidly obese.26,28 We similarly found that 
higher BMI was related to worse peak-exercise diastolic func-
tion, even within our very heterogeneous population. However, 
this association was not evident for those with a lower VO2peak, 
and so our hypothesis was only partly supported by the data. It 
is not clear why VO2peak was not associated with LVDD in the 
current study, as previous studies reported correlations between 
this parameter and LVDD.29 Indeed, it has been suggested that 
exercise E/E′ can distinguish between patients with exercise 
capacity of 8 METs or higher, which corresponds to VO2peak 
of ∼28 mL/kg/minute, compared to those with lower exercise 
capacity (less than 8 METs).30 However, the mean VO2peak in 
the current study was ∼18 mL/kg/minute (or ∼5 METs), which 
may limit the correlation. Furthermore, we used peak-exercise 
echocardiographic parameters to assess diastolic function, which 
are more sensitive than resting measures.17 An additional study 
reported a significant relationship between functional capac-
ity and LV diastolic function in healthy community–dwelling 
older adults (age .65 years).31 The difference between the cur-
rent study and the referred study was in the population studied; 
in the current study, only patients with T2DM who also have 
LVDD were included, which may explain the variance in results. 
In addition, the method used to assess aerobic capacity varied 
between studies; our study utilized the standard technique of 
indirect calorimetry to measure VO2peak, whereas earlier study 
used the less precise six-minute walking test. To further note in 
this population, exercise capacity and tolerance can be limited 
by diseases, such as that of the lung, eg, COPD7,8,32; however, 
in the current study, patients who have a history of lung disease 
that requires regular inhaler use were excluded. Our data fur-
ther suggest that in our group of patients, VO2peak and BMI are 
not correlated, which may indicate that improvement in VO2peak 
post-interventions may be independent of change in BMI.
Together, the results from the current study indicate that 
not all risk factors for cardiometabolic disease have the same 
predictor capacity for LVDD, and BMI appears to be superior 
for predicting LVDD in patients with T2DM when compared 
to aerobic power. Our findings suggest that the use of BMI 
is not only a cost-effective clinical tool but given the ease or 
measuring fatness is also an efficient way of taking a preventa-
tive approach to screening for disease risk predictors.
Higher BMI was not correlated with LV systolic func-
tion, in contrast to the previously published data.33 Our data 
Table 3. LV measures stratified as higher and lower 50% for BMI and VO2peak.
BMI (kg⋅M−2) VO2PEAk (ML⋅kg−1⋅MIn−1)
,50% .50% ,50% .50%
MV E/e' lateral 7.5 ± 0.6 11.40 ± 1.3* 10.5 ± 1.4 7.8 ± 0.9
MV E/e' septal 9.7 ± 0.5 12.8 ± 0.9** 11.8 ± 1.0 10.0 ± 0.7
MV e (m/s) 0.7 ± 0.1 0.8 ± 0.1* 0.7 ± 0.1 0.7 ± 0.1
MV dt (ms) 243.8 ± 21.2 244.6 ± 15.1 226.1 ± 16.8 250.1 ± 19.7
MV e/a 0.8 ± 0.1 0.8 ± 0.1 0.7 ± 0.1 0.9 ± 0.1
MV e' lateral (m/s) 0.10 ± 0.01 0.08 ± 0.01 0.07 ± 0.01 0.10 ± 0.01
MV e' septal (m/s) 0.07 ± 0.01 0.06 ± 0.002 0.06 ± 0.01 0.07 ± 0.01
ejection Fraction (%) 63.3 ± 1.6 63.2 ± 1.8 61.4 ± 1.5 65.9 ± 1.9^
notes: *P # 0.05, **P # 0.01, ***P # 0.001, and ^P = 0.07 between groups.
Abbreviations: BMi, body mass index; MV, mitral valve; dt, deceleration time; E, E wave for mitral inflow; E/A, ratio of E and A waves of mitral inflow; e′, early 
diastolic annular velocity; E/e′, ratio of E and e′; septal, septal MV annulus; lateral, lateral annulus.
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show that those with higher VO2peak tend to have a higher 
LVEF, but no significant correlation was found between the 
two variables. This finding is interesting as previous studies 
that examined the relationship between VO2peak and LVEF 
in patients with LV systolic dysfunction (systolic heart failure) 
reported no correlations between these factors.29 This supports 
the hypothesis that exercise capacity in patients with systolic 
heart failure is largely due to alteration in the periphery (ie, 
skeletal muscle).34 Future studies should explore which fac-
tors (central and peripheral) are responsible for the reduction 
in exercise capacity in patients with T2DM with preserved 
LVEF but compromised diastolic function.
A potential limitation of the current study is the relatively 
small sample size. Thus, in one sense, these new data should 
be seen as hypothesis generating. In addition, the inclusion of 
patients with T2DM who have already developed some degree 
of LVDD may limit the findings. This is however, also a strength 
of the study as for the first time we looked at a selected group of 
individuals who may represent this population more closely 
than all people with T2DM, irrespective of LV diastolic func-
tion. Finally, some patients have reported a smoking history, 
which may affect exercise capacity; yet, these patients represent 
the smoking habits that are present in the general population, 
which may assist with the generalization of the results.
conclusion
In conclusion, in individuals with T2DM with diastolic 
dysfunction, a higher BMI was associated with worsening 
diastolic function that is independent of their aerobic capac-
ity. The data provide a simple and practical approach to assist 
in identification of functional changes to the heart diastolic 
function in this population.
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